| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/16/2023 | NeuBase Therapeutics, Inc. | OHRP | Grant | Common stock | 54.2k | $0.00 | $0 | | 03/16/2023 |
| 03/18/2022 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common stock | 10k | $1.81 | $18.1k | | 03/18/2022 |
| 03/17/2022 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common stock | 10k | $1.74 | $17.4k | | 03/16/2022 |
| 03/16/2022 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common stock | 10k | $1.62 | $16.2k | | 03/16/2022 |
| 01/10/2022 | NeuBase Therapeutics, Inc. | OHRP | Grant | Employee stock option (right to buy) | 300k | $2.52 | $756k | | 01/10/2022 |
| 01/28/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Stock Option (Right to Buy) | 60k | $39.11 | $2.3M | | 01/28/2021 |
| 07/13/2020 | Phathom Pharmaceuticals, Inc. | PHAT | Grant | Stock Option (Right to Buy) | 85k | $29.43 | $2.5M | | 07/13/2020 |
| 02/27/2020 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 83.1k | $0.00 | $0 | | 02/27/2020 |
| 02/27/2020 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Performance-Based Restricted Stock Units | 166.2k | $0.00 | $0 | | 02/27/2020 |
| 01/22/2020 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 20.1k | $0.00 | $0 | | 01/22/2020 |
| 01/22/2020 | Amneal Pharmaceuticals, Inc. | AMRX | Payment of Exercise | Class A Common Stock | 7.3k | $5.13 | $37.5k | | 01/22/2020 |
| 11/13/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Stock Option | 163.7k | $2.75 | $450.1k | | 11/13/2019 |
| 11/13/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Disposition | Stock Option | 163.7k | $12.44 | $2M | | 11/13/2019 |
| 01/22/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 80.4k | $0.00 | $0 | | 01/22/2019 |
| 01/22/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Stock Option | 163.7k | $12.44 | $2M | | 01/22/2019 |